10-Q Filing

AGIOS PHARMACEUTICALS, INC. CIK: 1439222 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001439222-18-000014`
Period End Date	20180630
Filing Date	20180802
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	agio-20180630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 52 Cash Flow Statement 65 Comprehensive Income 12

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$102.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$210.32M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$138.72M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$506.58M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesCurrent`	$321.21M	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Collaboration receivable - related party	`CollaborationReceivableDuefromRelatedPartiesCurrent`	$2.45M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Collaboration receivable - related party	`CollaborationReceivableDuefromRelatedPartiesCurrent`	$19.33M	USD	Point-in-time
Collaboration receivable - other	`CollaborationReceivableOtherCurrent`	$440.00K	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Collaboration receivable - other	`CollaborationReceivableOtherCurrent`	-	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	125.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	57.93M	shares	Point-in-time
Royalty receivable - related party	`RoyaltyReceivableDuefromRelatedPartiesCurrent`	$1.57M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	48.83M	shares	Point-in-time
Royalty receivable - related party	`RoyaltyReceivableDuefromRelatedPartiesCurrent`	$1.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$15.54M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.66M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	57.93M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	48.83M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$445.26M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$753.78M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$143.81M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesNoncurrent`	$219.72M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$24.43M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$24.13M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$595.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$891.00K	USD	Point-in-time
Total assets	`Assets`	$614.40M	USD	Point-in-time
Total assets	`Assets`	$998.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$22.77M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$17.32M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$25.79M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$34.03M	USD	Point-in-time
Deferred revenue - related party	`DeferredRevenueCurrent`	$37.84M	USD	Point-in-time
Deferred revenue - related party	`DeferredRevenueCurrent`	$41.13M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$625.00K	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$301.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$94.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$84.87M	USD	Point-in-time
Deferred revenue, net of current portion - related party	`DeferredRevenueNoncurrent`	$72.41M	USD	Point-in-time
Deferred revenue, net of current portion - related party	`DeferredRevenueNoncurrent`	$125.80M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$18.16M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$17.82M	USD	Point-in-time
Total liabilities	`Liabilities`	$175.09M	USD	Point-in-time
Total liabilities	`Liabilities`	$238.89M	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at June 30, 2018 and December 31, 2017	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 57,932,639 and 48,826,153 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$58.00K	USD	Point-in-time
Common stock, $0.001 par value; 125,000,000 shares authorized; 57,932,639 and 48,826,153 shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$49.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.17B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.74B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.39M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-798.06M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-918.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$823.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$375.50M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$998.24M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$614.40M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Collaboration revenue - related party	`CollaborationRevenueRevenueFromRelatedParties`	$26.40M	USD	1 Quarter
Collaboration revenue - related party	`CollaborationRevenueRevenueFromRelatedParties`	$11.35M	USD	1 Quarter
Collaboration revenue - related party	`CollaborationRevenueRevenueFromRelatedParties`	$33.75M	USD	2 Qtrs
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	2 Qtrs
Collaboration revenue - related party	`CollaborationRevenueRevenueFromRelatedParties`	$21.85M	USD	2 Qtrs
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	1 Quarter
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$2.49M	USD	1 Quarter
Reduction of research and development expenses	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$5.26M	USD	2 Qtrs
Collaboration revenue - other	`CollaborationRevenueOtherRevenues`	-	USD	2 Qtrs
Collaboration revenue - other	`CollaborationRevenueOtherRevenues`	$12.44M	USD	1 Quarter
Collaboration revenue - other	`CollaborationRevenueOtherRevenues`	$12.44M	USD	2 Qtrs
Collaboration revenue - other	`CollaborationRevenueOtherRevenues`	-	USD	1 Quarter
Royalty revenue related party	`RoyaltyRevenue`	-	USD	2 Qtrs
Royalty revenue related party	`RoyaltyRevenue`	$2.99M	USD	2 Qtrs
Royalty revenue related party	`RoyaltyRevenue`	-	USD	1 Quarter
Royalty revenue related party	`RoyaltyRevenue`	$1.57M	USD	1 Quarter
Total revenue	`Revenues`	$11.35M	USD	1 Quarter
Total revenue	`Revenues`	$21.85M	USD	2 Qtrs
Total revenue	`Revenues`	$40.41M	USD	1 Quarter
Total revenue	`Revenues`	$49.18M	USD	2 Qtrs
Research and development (net of $2,489 and $5,625 of cost reimbursement from related party for the three and six months ended June 30, 2017)	`ResearchAndDevelopmentExpense`	$86.73M	USD	1 Quarter
Research and development (net of $2,489 and $5,625 of cost reimbursement from related party for the three and six months ended June 30, 2017)	`ResearchAndDevelopmentExpense`	$164.95M	USD	2 Qtrs
Research and development (net of $2,489 and $5,625 of cost reimbursement from related party for the three and six months ended June 30, 2017)	`ResearchAndDevelopmentExpense`	$79.82M	USD	1 Quarter
Research and development (net of $2,489 and $5,625 of cost reimbursement from related party for the three and six months ended June 30, 2017)	`ResearchAndDevelopmentExpense`	$142.55M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$51.18M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$26.63M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.13M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$30.95M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$113.36M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$173.50M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$95.95M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$216.14M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-151.65M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-166.96M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-72.95M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-84.60M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$2.40M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$4.20M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.52M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$7.39M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-149.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-83.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-159.57M	USD	2 Qtrs
Net loss per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.78	USD	1 Quarter
Net loss per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-3.35	USD	2 Qtrs
Net loss per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-2.81	USD	2 Qtrs
Net loss per share basic and diluted (usd per share)	`EarningsPerShareBasicAndDiluted`	$-1.19	USD	1 Quarter
Weighted-average number of common shares used in computing net loss per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	44.53M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	56.71M	shares	2 Qtrs
Weighted-average number of common shares used in computing net loss per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	46.75M	shares	1 Quarter
Weighted-average number of common shares used in computing net loss per share basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	57.72M	shares	1 Quarter

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-149.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-83.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-159.57M	USD	2 Qtrs
Depreciation	`Depreciation`	$3.46M	USD	2 Qtrs
Depreciation	`Depreciation`	$3.16M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$22.92M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$30.98M	USD	2 Qtrs
Net amortization of premium and discounts on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-94.00K	USD	2 Qtrs
Net amortization of premium and discounts on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.29M	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets1`	$20.00K	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets1`	$-40.00K	USD	2 Qtrs
Collaboration receivable - related party	`IncreaseDecreaseInCollaborationReceivableDueFromRelatedPartiesCurrent`	$16.88M	USD	2 Qtrs
Collaboration receivable - related party	`IncreaseDecreaseInCollaborationReceivableDueFromRelatedPartiesCurrent`	$-44.00K	USD	2 Qtrs
Collaboration receivable - other	`IncreaseDecreaseInCollaborationReceivableOtherCurrent`	$440.00K	USD	2 Qtrs
Collaboration receivable - other	`IncreaseDecreaseInCollaborationReceivableOtherCurrent`	-	USD	2 Qtrs
Royalty receivable - related party	`IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent`	$351.00K	USD	2 Qtrs
Royalty receivable - related party	`IncreaseDecreaseinRoyaltyReceivableDuefromRelatedPartiesCurrent`	-	USD	2 Qtrs
Tenant improvement and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	-	USD	2 Qtrs
Tenant improvement and other receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-2.64M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.42M	USD	2 Qtrs
Prepaid expenses and other current and non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.41M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-6.20M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.93M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-7.84M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-2.39M	USD	2 Qtrs
Deferred revenue - related party	`IncreaseDecreaseInDeferredRevenue`	$-11.18M	USD	2 Qtrs
Deferred revenue - related party	`IncreaseDecreaseInDeferredRevenue`	$-10.64M	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$16.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$1.65M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-166.40M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-133.06M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$592.66M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$468.56M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$331.67M	USD	2 Qtrs
Proceeds from maturities and sales of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$303.71M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.33M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.79M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-166.17M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-263.79M	USD	2 Qtrs
(Reimbursement) payment of public offering costs	`PaymentsOfStockIssuanceCosts`	$-104.00K	USD	2 Qtrs
(Reimbursement) payment of public offering costs	`PaymentsOfStockIssuanceCosts`	$391.00K	USD	2 Qtrs
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$270.25M	USD	2 Qtrs
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$516.20M	USD	Point-in-time
Proceeds from public offering of common stock, net of commissions	`ProceedsFromIssuanceOfCommonStock`	$516.21M	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$6.84M	USD	2 Qtrs
Net proceeds from stock option exercises and employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$21.97M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$277.20M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$537.78M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$107.60M	USD	2 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-22.04M	USD	2 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$102.72M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$210.32M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$138.72M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$102.72M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$210.32M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$138.72M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$160.75M	USD	Point-in-time
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.38M	USD	2 Qtrs
Additions to property and equipment in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$1.36M	USD	2 Qtrs
Proceeds from stock option exercises in other current assets	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	-	USD	2 Qtrs
Proceeds from stock option exercises in other current assets	`ProceedsFromStockOptionsExercisedInOtherCurrentAssets`	$3.00K	USD	2 Qtrs
Public offering costs in other receivables, net of amounts in accounts payable and accrued expenses	`PublicOfferingCostsInOtherCurrentAssets`	$125.00K	USD	2 Qtrs
Public offering costs in other receivables, net of amounts in accounts payable and accrued expenses	`PublicOfferingCostsInOtherCurrentAssets`	-	USD	2 Qtrs

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-149.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-83.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-159.57M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-438.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$245.00K	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.01M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-337.00K	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-160.58M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-68.50M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-83.52M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-149.59M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.